Возраст домена | 23 года |
Дата окончания | Истек срок регистрации |
PR | 3 |
ИКС | |
Страниц в Google | 71 |
Страниц в Яндексе | 80 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 11005573 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
AVS | Advanced Vision Science, Inc
n/a
n/a
UTF-8
24.63 КБ
451
3 514 симв.
2 961 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
alibaba.com | 2 | 7 |
0 | 161 | 99 | |
advanced-vision-care.com | 1 | 2 |
0 | 12785460 | Нет данных | |
advanced-vision.org | 1 | 2 |
0 | 12923324 | Нет данных | |
advancedvision.org | 1 | 2 |
0 | 12277815 | Нет данных | |
advancedvision.biz | 1 | 1 |
0 | Нет данных | Нет данных | |
advancedvisioncolumbia.com | 1 | 1 |
0 | 19175087 | Нет данных | |
advancedvisioncenters.com | 1 | 1 |
0 | Нет данных | Нет данных | |
advancedvisioncareflorida.com | 1 | n/a | 0 | 21091202 | Нет данных | |
advancedvisionassociates.com | 1 | 1 |
0 | 16781007 | Нет данных | |
1hr-optical.com | 1 | 1 |
0 | 10728085 | Нет данных | |
Еще 27 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 7 Марта 2013 ) | |
Количество ссылок на сайт | 3 |
Количество доменов, которые ссылаются на сайт | 3 |
Количество найденных анкоров | 3 |
Исходящие (внешние) ссылки домена | 22 |
Количество доменов, на которые ссылается сайт | 10 |
Количество исходящих анкоров | 9 |
Внешние ссылки главной страницы ( 30 ) | |
santen.com/en/ | Santen Worldwide |
santen.com/en/about/ | About Santen |
ssl4.eir-parts.net/doc/4536/tdnet/1773994/00.pdf | Launch of Alesion LX Ophthalmic Solution 0.1% in Japan |
ssl4.eir-parts.net/doc/4536/tdnet/1764796/00.pdf | Santen Reports the 2nd Quarter Fiscal 2019 Consolidated Performance |
ssl4.eir-parts.net/doc/4536/tdnet/1764781/00.pdf | Santen Announces Proposed Dividend Change |
ssl4.eir-parts.net/doc/4536/tdnet/1758188/00.pdf | Santen Donates to the Disaster Caused by Typhoon Hagibis |
ssl4.eir-parts.net/doc/4536/tdnet/1752522/00.pdf | Receipt of NDA Approval of Alesion LX for anti-allergy in Japan, and Joint Sales Promotion Contract with Mitsubishi Tanabe Pharm... |
ssl4.eir-parts.net/doc/4536/tdnet/1749940/00.pdf | Sponsorship Agreement for IBSA Blind Football Asian Championships 2019 signed between Santen, IBF Foundation, and JBFA |
ssl4.eir-parts.net/doc/4536/tdnet/1748459/00.pdf | Santen Announces Topline Pivotal Data for DE-128 (MicroShunt) Demonstrating Reductions in Intraocular Pressure and Medication Us... |
ssl4.eir-parts.net/doc/4536/tdnet/1737756/00.pdf | Santen Reports the 1st Quarter Fiscal 2019 Consolidated Performance |
ssl4.eir-parts.net/doc/4536/tdnet/1733556/00.pdf | Notice on the Completion of Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program |
ssl4.eir-parts.net/doc/4536/tdnet/1728755/00.pdf | Santen Included in All Four ESG Investment Indices Selected by GPIF |
ssl4.eir-parts.net/doc/4536/tdnet/1724984/00.pdf | Oxford Biomedica and Santen enter R&D collaboration and Option & Licence Agreement for development of gene therapy vectors for i... |
ssl4.eir-parts.net/doc/4536/tdnet/1724490/00.pdf | Notice on the Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program |
ssl4.eir-parts.net/doc/4536/tdnet/1720427/00.pdf | Santen Chooses SAP S/4HANA Cloud and Other SAP Solutions to Reform Key Operation System and Strengthen Global Management Structu... |
ssl4.eir-parts.net/doc/4536/tdnet/1699822/00.pdf | Santen Reports Fiscal 2018 Consolidated Performance |
ssl4.eir-parts.net/doc/4536/tdnet/1699830/00.pdf | Notice of Board of Director and Corporate Auditor Nominations |
ssl4.eir-parts.net/doc/4536/tdnet/1697090/00.pdf | Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in ... |
ssl4.eir-parts.net/doc/4536/tdnet/1693279/00.pdf | Santen Announces Launch of LENTIS Comfort, Low-Add Segmental Intraocular Lens for Cataract Treatment in Japan |
ssl4.eir-parts.net/doc/4536/tdnet/1686951/00.pdf | Santen Announces Cancellation of Treasury Shares |
ssl4.eir-parts.net/doc/4536/tdnet/1686414/00.pdf | Santen Announces Completion of Repurchase of Own Shares |
ssl4.eir-parts.net/doc/4536/tdnet/1683851/00.pdf | Notice of Corporate Officer Appointments |
ssl4.eir-parts.net/doc/4536/tdnet/1682592/00.pdf | Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16 |
ssl4.eir-parts.net/doc/4536/tdnet/1682130/00.pdf | Santen Selected and Launches Photo-Crosslinking Research and Development Project for Pathologic Myopia Treatment for CiCLE Progr... |
ssl4.eir-parts.net/doc/4536/tdnet/1682131/00.pdf | Santen Selected and Launches Gene Therapy Drug Research and Development Project for Inherited Ocular Disease Treatment for CiCLE... |
ssl4.eir-parts.net/doc/4536/tdnet/1681098/00.pdf | Santen Announces Status of Repurchase of Own Shares |
ssl4.eir-parts.net/doc/4536/tdnet/1678258/00.pdf | Santen Announces Repurchase of Own Shares |
ssl4.eir-parts.net/doc/4536/tdnet/1669677/00.pdf | Santen Reports the 3rd Quarter Fiscal 2018 Consolidated Performance |
ssl4.eir-parts.net/doc/4536/tdnet/1667185/00.pdf | Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Sponsoring World Glaucoma We... |
ndic.com | WordPress Website Design Santa Barbara by NDIC |
Внутренние ссылки главной страницы ( 15 ) | |
advancedvisionscience.com/ | Home |
advancedvisionscience.com/contact/ | Contact |
advancedvisionscience.com/sitemap/ | Sitemap |
# | I |
advancedvisionscience.com/about-avs/ | About Us |
advancedvisionscience.com/social-responsibility/ | Social Responsibility |
advancedvisionscience.com/productsrd/ | Products/R&D |
advancedvisionscience.com/careers/ | Careers |
advancedvisionscience.com/customer-information/ | Customer Information |
/en/csr/ | Corporate Social Responsibility (CSR) page on our website has been updated |
/en/news/20190125.pdf | Santen's Tampere manufacturing facility to be acquired by NextPharma |
/en/news/20190108.pdf | Santen Updates Pipeline in Corporate Presentation of January 8, 2019 |
advancedvisionscience.com/blog/ | News List |
advancedvisionscience.com/privacy-policy/ | Privacy Policy |
advancedvisionscience.com/terms-of-use/ | Terms of Use |
Domain Name: ADVANCEDVISIONSCIENCE.COM
Registry Domain ID: 32081735_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enom.com
Updated Date: 2018-07-14T06:00:08Z
Creation Date: 2000-07-29T17:57:40Z
Registry Expiry Date: 2020-07-29T17:57:40Z
Registrar: eNom, Inc.
Registrar IANA ID: 48
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.CORPSITE.COM
Name Server: NS2.CORPSITE.COM
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-10-02T07:52:04Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
США - 216.185.152.144
Incapsula
Affinity Internet
HTTP/1.1 200 OK
Date: Tue, 03 Dec 2019 23:16:07 GMT
Server: Apache/2.4.41
Vary: User-Agent,Accept-Encoding
Accept-Ranges: bytes
Content-Length: 25218
Cache-Control: max-age=0, public
Expires: Tue, 03 Dec 2019 23:16:07 GMT
X-Powered-By: WP Rocket/3.4.0.5
Connection: close
Content-Type: text/html; charset=UTF-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"